Cencora’s Participation in the White House Cancer Moonshot’s New Pilot to Mitigate Pediatric Cancer Drug Shortages
Cencora is proud to serve as a participant in the White House Cancer Moonshot’s initiative , which aims to mitigate shortages of critical pediatric cancer medications. As a leader in pharmaceutical supply chain operations and distribution, Cencora is committed to advance solutions that create stability for our nation’s pharmaceutical products and help to ensure healthcare providers have timely and reliable access to medications. We believe continued collaboration with multiple stakeholders across the industry is critical to strengthen the supply chain and address this complex, multi-faceted issue.
- Heather Zenk, RPh, PharmD, President of the U.S. Supply Chain, Cencora
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Related content
Press release
Cencora Launches Accelerate Pharmacy Solutions to Enhance Support for Hospital and Health System Customers
December 6, 2024
Press release
Cencora to Host Inaugural Product Showcase
November 26, 2024
Leadership statement
Sustaining Progress Toward DSCSA Compliance Following FDA Exemptions
November 11, 2024